The report “ 3D Cell Culture Market by Technology“ (Scaffold Based, Scaffold Free) by Application (Cancer Research, Stem Cell Technology, Primary Cell Research, Tissue Engineering & Regenerative Medicines, Human Cell Lines, Tumor Xenografting, Drug Discovery, and Others) by End-Users (Research Laboratories, Biotechnology and Pharmaceuticals Industries, Hospitals and Diagnostics Centers and Others) – Global Forecast to 2021 „ , and the market segments of the technology, product, application, and region.
The global 3D cell culture market size is expected to reach $ 1345.2 million by 2021 , at a CAGR of 23.6% during the forecast period of 2016 to 2021.
Browse 66 market data tables with 72 figures spread through 158 pages and in-depth TOC on „3D Cell Culture Market“
http://www.marketsandmarkets.com/Market-Reports/3d-cell-culture-market-191072847.html
Industry Insights:
On the basis of technology, the 3D cell culture market is segmented into scaffold-based and scaffold free. The scaffold-based segment is further categorized into hydrogels / ECM analogs, solid scaffolds, micropatterned surfaces, and others. Scaffold free segment is further classified in attachment resistant and suspension cultures. The Scaffold-based segment is expected to become the largest share of the global market in 2016. Due to the variety of material and structural choices for scaffold, they are widely used in various applications in the market. So, as they can grow on top of the cells, they can easily diminish their growth.
The cell culture market is segmented into cell-based assays / toxicity screening, cancer cell research, 3D printing / microfluidics, regenerative medicine, and in vivo applications for stem cell. The cancer cell research segment is expected to account for the largest share of this market. The rising incidences of cancer have been created to develop new treatment options. As cell culture techniques are used in the R & D and production of vaccines, drugs, therapeutics, and antibiotics, this factor can be expected to drive the market for 3D cell culture.
End users of the 3D cell culture market are research laboratories & institutes, biotechnology & pharmaceutical industries, and hospitals & diagnostic centers. The Biotechnology & Pharmaceuticals Industries Group is pleased to announce that it has completed the largest share of the global market in 2016. The rising incidences of cancer
Get The PDF Brochure For This Report :
http://www.marketsandmarkets.com/pdfdownload.asp?id=191072847
Geographical Scenario:
Geographically, the 3D cell culture market is dominated by North America, followed by Europe, Asia-Pacific, and the Rest of the World (RoW). Growth in the North American segment is increasingly driven by increasing government support in the form of grants and funding, rising incidences of cancer, expanding biopharmaceutical industry, and launch of new products in the market.
Scope of the Report:
This report categorizes the 3D cell culture market into the following segments:
- 3D Cell Culture Market, By Technology
- 3D Cell Culture Market, By Application
- 3D Cell Culture Market, By End User
- 3D Cell Culture Market, By Region
Customization Options:
- Company Information: Detailed company profiles of five or more market players
- Opportunities Assessment: A detailed report underlining the various growth opportunities in the market
Request a sample of the report:
http://www.marketsandmarkets.com/requestsample.asp?id=191072847
Target Audience:
- Pharmaceutical and Biopharmaceutical Companies
- Manufacturers of Cell Culture Equipment
- Contract Research Organizations
- Life Science Research Institutes
- Venture capitalists
- Research and Consulting Firms
Industry Leaders:
The prominent players in the 3D cell culture market include 3D Biotek LLC (US), Becton, Dickinson and Company (US), Corning Incorporated (US), Thermo Fisher Scientific (US), Global Cell Solutions, Inc. (US), Kuraray Co. ltd. (Japan), Lonza Group (Switzerland), Merck & Co., Inc. (US), Sigma Aldrich Corporation (US), Reinnervate Ltd, (a subsidiary of ReproCELL) (UK), and others.